AMPE News and Press, Ampio Pharmaceuticals Inc. From 09/09/23

2023-09-09 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

2023-08-31 08:41:31 ET More on Ampio Pharmaceuticals Ampio stock jumps ~20% after CEO letter on drug program, reorganization Ampio Pharmaceuticals to implement 1-for-15 reverse stock split Ampio announces 55% reduction of staff as key development program ends ...

Ampio Pharmaceuticals Announces Reverse Stock Split PR Newswire ENGLEWOOD, Colo. , Aug. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that its Board of Directors has approved a 20-to-1 reverse stock spl...

2023-06-22 09:30:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The biotech sector will always house stocks with explosive upside potential. The very nature of the sector ensures that will continue to be the case. Developing breakthrough pharmaceuticals a...

2023-05-11 07:31:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we check out the latest news on Thursday! Moving stocks this morning are earnings reports, insider buying, and ...

2023-04-18 12:38:08 ET Ampio Pharmaceuticals ( NYSE: AMPE ) stock rose ~21% on Tuesday following a letter from Chairman Kevin Buchi and CEO Mike Martino to the company's to stockholders updating about about potential osteoarthritis (OA) drug AR-300 and reorga...

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS PR Newswire ENGLEWOOD, Colo. , Jan. 17, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin Buchi...

Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards PR Newswire ENGLEWOOD, Colo. , Dec. 27, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company") today announced that it has received notificatio...

Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension PR Newswire ENGLEWOOD, Colo. , Nov. 17, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE) (the "Company") received notification from NYSE American LL...

Ampio Pharmaceuticals ( OTC:AMPE ) said Tuesday it will implement a 1-for-15 reverse stock split . No fractional shares will be outstanding after the reverse split. Ampio ( OTC:AMPE ) had ~226.3M shares outstanding prior to the reverse split. The reverse stock...